2026 MP Profile - Lu, Nancy - National
2026 MP Profile
Sector evidence
Sector body
June 2026
Next review not yet scheduled
New Zealand
Medium confidence
published
SNZ editorial review
Evidence boundary: This record summarises the cited source. It does not establish local availability, individual eligibility, or professional advice.
Short Answer
Nancy Lu is a backbench list MP with no ministerial, associate ministerial, or opposition spokesperson portfolios.
Key Points
- •Chartered Accountant (CA) — trained at PwC (auditor) and EY (tax consultant), also worked at Fonterra
- •Auckland Council — Lead financial strategist (2020–2022)
- •Board member: Chinese New Settlers Services Trust (supports new Chinese immigrants); ContainerCo (NZ) Ltd
- •Trustee: NZ Chinese Language Week Charitable Trust; AIESEC In Auckland Incorporated
- •University of Auckland — BCom (first-class honours, international business & accounting), did not complete LLB
- •Harvard Kennedy School of Government — Master of Public Administration (May 2023)
Full Summary & Notes
Nancy Lu is a backbench list MP with no ministerial, associate ministerial, or opposition spokesperson portfolios. Her committee roles (Finance and Expenditure member, Regulations Review Deputy Chair) have tangential relevance to seniors issues through fiscal scrutiny of NZ Super, health budgets, and aged care regulation, but she is not a leading voice or decision-maker on any seniors-relevant portfolio. She has no public statements on aged care, NZ Super, retirement housing, dementia, elder abuse, disability support, palliative care, or seniors policy. Her parliamentary activity focuses on economic/fiscal matters, ethnic communities, law and order, and small business. - ❌ Not a Minister or Associate Minister in any seniors-touching portfolio - ❌ Not an opposition spokesperson for Health, Social Development, Housing, or Seniors - ❌ Not Chair or Deputy Chair of Health, Social Services, or any seniors-relevant committee - ❌ No electorate with high 65+ population pressures to advocate on - ❌ No public positions on seniors-specific issues - ✅ Finance and Expenditure Committee member — tangential relevance to NZ Super funding, health expenditure The closest health-relevant activity is her work presenting a petition on breast cancer drug funding (see below), which tangentially relates to health equity and pharmaceutical funding for older adults. - Health supplements from GMP Pharmaceuticals NZ — potential interest in supplements/nutraceutical sector (minor; received as gift
Read bundled source notes
The saved source file may include fuller notes and references than the indexed summary. Check its dates and evidence limits.
Loading saved source notes…
Document Details & Metadata
Related Resources
Historical FY2024 operator report on care occupancy, resident and employee feedback, development, audited financial statements, climate scenarios and governance; underlying profit and care-quality narrative have separate assurance limits.
Its Martin Oettli profile records his June 2011 start as Real Living chief executive, growth of the group from one Pakuranga village to four Auckland villages, two with co-located care, and his prior executive, governance and international sector experience.
FY2024 care operator report on high-acuity beds, employee and resident feedback, RConnect staffing, community activity, new home-support plans and audited financial results; 49 PDF spreads contain the numbered report through page 95.
Historical FY2025 report covering village and co-located care capacity, mixed unit/suite completions, workforce feedback, development plans, emissions accounting and audited financial statements; portfolio excludes the Palmerston North joint venture.
42-page FY2026 financial annual report with a short portfolio and leadership overview, audited statements, valuation and resident-loan notes, planned development and limited resident-feedback reporting; separate from the two-page results release.
Two-page issuer results release linking unaudited underlying EBITDA, mixed care-suite/apartment completions and portfolio growth to the year ended March 2026; should be read with the full financial annual report, doc-0194.